Research Library — Page 14 | Reta Compare

402 research articles. Page 14 of 17.

Articles

• Eli Lilly Highlights Promising Results for Retatrutide in Weight Management
• Exploring Clinician Perspectives on Retatrutide's Promising Data
• Eli Lilly's Retatrutide Demonstrates Significant Weight Loss in Latest Phase 3 Trial
• Retatrutide Shows Promising Results in Obesity and Knee Osteoarthritis Clinical Trials
• Retatrutide Shows Promising Near-30% Weight Loss in Recent Data
• Retatrutide Shows Significant Weight Loss and Pain Relief in Phase 3 Trial
• Retatrutide Demonstrates Significant Weight Loss and Knee Pain Reduction in Phase 3 Trial
• Exploring Retatrutide: A Promising New Approach to Weight Management
• Positive Phase III Trial Results for Retatrutide Enhance Its Research Potential
• Retatrutide Achieves Significant Weight Loss in Trials Amid Emerging Safety Concerns
• Eli Lilly's Retatrutide Shows Promising Results in Late-Stage Obesity Trials
• Retatrutide Shows Promising Weight Loss Data in Recent Research
• Retatrutide's Promising Trial Results Signal a Shift in Obesity Treatment Landscape
• Eli Lilly's Phase 3 Trial Results Highlight Retatrutide's Potential in Obesity Treatment
• Retatrutide Demonstrates Significant Weight Loss and Alleviation of Knee Pain
• Exploring the Weight Loss Potential and Market Viability of Retatrutide
• Recent Weight Loss Trial Highlights Promising Efficacy of Retatrutide
• Retatrutide Shows Promising Weight Loss and Pain Relief in Phase 3 Trial
• Exploring Retatrutide: Implications of Triple Agonists in Metabolic Health
• Eli Lilly's Retatrutide: Insights Ahead of Upcoming Trial Results
• Concerns Over Fake Weight-Loss Drugs Amid Retatrutide's Rise in Popularity
• New Insights into Retatrutide: Implications for Obesity Management
• Exploring the Potential of Retatrutide for Effective Weight Management
• Exploring Retatrutide: Promising Weight Loss with Uncertain Safety Profile
• U.K. Regulators Target Illicit Production of Retatrutide and Tirzepatide